Edition:
United Kingdom

Adamas Pharmaceuticals Inc (ADMS.OQ)

ADMS.OQ on NASDAQ Stock Exchange Global Market

18.82USD
19 Sep 2018
Change (% chg)

$0.15 (+0.80%)
Prev Close
$18.67
Open
$18.65
Day's High
$19.08
Day's Low
$18.27
Volume
116,893
Avg. Vol
165,865
52-wk High
$43.98
52-wk Low
$17.68

Chart for

About

Adamas Pharmaceuticals, Inc. is a pharmaceutical company. The Company is engaged in developing medicines to manage the daily lives of those affected by chronic neurologic disorders. It offers a platform based on an understanding of time dependent biologic effects of disease activity and drug response to achieve relief without... (more)

Overall

Beta: 0.78
Market Cap(Mil.): $520.30
Shares Outstanding(Mil.): 22.51
Dividend: --
Yield (%): --

Financials

  ADMS.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -2.98 -- --
ROI: -44.88 1.78 14.61
ROE: -51.05 3.27 16.33

BRIEF-Adamas Announces Final Results From Phase 3 Open-Label Study Of Gocovri

* ADAMAS ANNOUNCES FINAL RESULTS FROM THE TWO-YEAR PHASE 3 OPEN-LABEL STUDY OF GOCOVRI™ IN PARKINSON’S DISEASE PATIENTS WITH DYSKINESIA

19 Apr 2018

BRIEF-Adamas Announces First Patient Enrolled In Phase 3 Trial Of ADS 5102 In Multiple Sclerosis Patients With Walking Impairment

* 5102 IN MULTIPLE SCLEROSIS PATIENTS WITH WALKING IMPAIRMENT Source text for Eikon: Further company coverage:

03 Apr 2018

Earnings vs. Estimates